PTSD Testing & Assessment

Professional PTSD Testing & Assessment at KwikPsych

Accurate PTSD diagnosis is the foundation of effective treatment. At KwikPsych, we use comprehensive, validated assessment tools and evidence-based diagnostic protocols to:

• Confirm PTSD diagnosis and rule out related conditions
• Measure symptom severity and profile
• Identify trauma types and triggers
• Screen for comorbid mental health conditions
• Assess suicide and safety risk
• Establish baseline for tracking treatment progress
• Provide detailed recommendations for therapy and medication

A thorough assessment ensures you receive the correct diagnosis—preventing months of ineffective treatment—and creates a roadmap for your recovery.

Why Formal PTSD Assessment Matters

Many trauma survivors never receive a proper diagnosis. Others receive incorrect diagnoses (anxiety, depression, ADHD, personality issues) when the underlying problem is PTSD. This delays appropriate treatment and perpetuates suffering.

Common Diagnostic Errors:

Mistaken for General Anxiety

The hyperarousal of PTSD (elevated heart rate, hypervigilance, startle response) looks like anxiety. However, anxiety is typically "free-floating" worry about future threats, while PTSD hyperarousal is fear-based reactivity to trauma reminders—a crucial distinction affecting treatment.

Mistaken for Depression

The emotional numbing, anhedonia (loss of pleasure), guilt, and concentration problems in PTSD overlap with depression. But untreated PTSD perpetuates depression; treating only depression misses the trauma component.

Mistaken for ADHD

Intrusive trauma memories and hypervigilance disrupt concentration, mimicking ADHD. However, ADHD involves pervasive attention problems since childhood, while PTSD concentration problems are trauma-specific and resolve as PTSD improves.

Mistaken for Personality Problems

Irritability, trust difficulties, relationship strain, and emotional dysregulation stemming from trauma are sometimes labeled as "personality disorders" when they're actually adaptive responses to traumatic experiences.

Formal assessment with validated tools prevents these errors and ensures you receive the right treatment for the right condition.

PTSD Assessment Tools and Protocols at KwikPsych

PCL-5 (PTSD Checklist for DSM-5)

The PCL-5 is the most widely used self-report screening and diagnostic tool for PTSD. It directly aligns with DSM-5-TR diagnostic criteria.

What It Measures

The PCL-5 contains 20 items assessing the four symptom clusters of PTSD:

Cluster 1: Intrusion (4 items)

• Repeated, unwanted memories of the trauma
• Nightmares related to the trauma
• Flashbacks (feeling as though the trauma is happening now)
• Emotional or physical reactions to reminders of the trauma

Cluster 2: Avoidance (2 items)

• Avoiding thoughts or feelings about the trauma
• Avoiding reminders (people, places, activities, objects, situations)

Cluster 3: Negative Changes in Cognition and Mood (7 items)

• Trouble remembering important parts of the trauma
• Negative beliefs about yourself, others, or the world
• Blame of self or others for the trauma
• Negative emotions (fear, anger, guilt, shame, etc.)
• Loss of interest in activities you enjoyed
• Feeling distant or cut off from others
• Inability to feel positive emotions

Cluster 4: Alterations in Arousal and Reactivity (6 items)

• Reckless or self-destructive behavior
• Hypervigilance
• Exaggerated startle response
• Difficulty concentrating
• Sleep problems
• Irritability or aggression

Item 20: Functional Impairment

• How much have these problems interfered with work, home, school, relationships, or other important parts of your life?

How It's Administered

At KwikPsych, you'll complete the PCL-5:

• Format: Self-report questionnaire (written or electronic)
• Time to Complete: 5-10 minutes
• Setting: Office, telehealth, or at home
• Frequency: At baseline, weekly during active treatment, and at follow-ups

Scoring and Interpretation

Each item is rated on a 5-point scale (0 = Not at all, 4 = Extremely):

Total Score Range: 0-80

Scoring Interpretation:

• 0-10: Minimal PTSD symptoms
• 11-20: Mild PTSD symptoms
• 21-30: Moderate PTSD symptoms
• 31-40: Moderate-to-severe PTSD symptoms
• 41+: Severe PTSD symptoms

Clinical Cutoff for PTSD Diagnosis:

• Score ≥31: Suggests probable PTSD
• Score ≥38: Consistent with PTSD diagnosis
• (Combined with clinical interview confirming DSM-5-TR criteria and functional impairment)

Tracking Treatment Progress:

Your PCL-5 score is repeated throughout treatment. Expected progression:

• Baseline: Maybe 50 (moderate-severe PTSD)
• Week 4: 45 (beginning improvement)
• Week 8: 35 (noticeable improvement)
• Week 12: 25 (significant improvement)
• Week 16: 15 (substantial recovery)
• Goal: <11 (remission range)

CAPS-5 (Clinician-Administered PTSD Scale for DSM-5)

The CAPS-5 is the gold-standard, most comprehensive PTSD diagnostic interview. While PCL-5 is a screening tool, CAPS-5 provides definitive diagnostic confirmation.

What CAPS-5 Includes

30-Item Symptom Severity Assessment

Detailed exploration of each of the four PTSD symptom clusters with specific probing questions about:

• Frequency of symptoms
• Intensity of symptoms
• Distress caused by symptoms
• Functional impact of each symptom

Example CAPS-5 Questions:

• "How often in the past month have you had unwanted memories of the trauma?"
• "When you think about the trauma, how strong is the physical feeling in your body?"
• "Has the trauma affected your relationships with family or friends?"
• "How angry have you been since the trauma?"

Behavioral Observations

During the interview, the clinician notes:

• Affect and emotional response
• Ability to tolerate discussing trauma
• Signs of dissociation or flashback activation
• Overall distress level

Trauma History and Onset

• Detailed exploration of the traumatic event(s)
• Onset of symptoms (acute vs. delayed-onset)
• Timeline of symptom development

Functional Impact Assessment

• How symptoms interfere with work
• Impact on relationships and social functioning
• Effect on self-care and daily activities
• Determination of whether impairment meets diagnostic threshold

Differential Diagnosis Probing

The clinician assesses for:

• Substance use contributions to symptoms
• Medical conditions mimicking PTSD
• Other mental health disorders
• Consistency with PTSD vs. other diagnoses

How CAPS-5 Is Administered

Format: Clinician-administered structured interview (Dr. Thangada or trained clinician)

Duration: 45-90 minutes (can be split over multiple sessions)

Setting: In-person (preferred) or telehealth

Frequency: Usually administered once at baseline; sometimes readministered at treatment completion for formal diagnostic re-assessment

Scoring CAPS-5

Symptom Severity Scoring (0-4 per symptom):

• 0 = Absent
• 1 = Mild/subthreshold
• 2 = Moderate
• 3 = Severe
• 4 = Extreme/incapacitating

Total Symptom Severity Score: 0-80

Functional Impairment Rating: 0-8

• 0 = None
• 2 = Mild
• 4 = Moderate
• 6 = Severe
• 8 = Extreme

PTSD Diagnosis Criteria Using CAPS-5:

A PTSD diagnosis requires:

• At least 1 intrusion symptom scoring ≥2
• At least 1 avoidance symptom scoring ≥2
• At least 2 negative cognition/mood symptoms scoring ≥2
• At least 2 arousal/reactivity symptoms scoring ≥2
• Functional impairment severity ≥2

Interpretation:

• Score 0-11: No or minimal PTSD
• Score 12-22: Mild PTSD
• Score 23-34: Moderate PTSD
• Score 35-52: Severe PTSD
• Score 53-80: Extreme PTSD

Why CAPS-5 Is the Gold Standard

• Diagnostic Certainty: Confirms whether you meet formal PTSD diagnostic criteria
• Comprehensive: Explores nuances and functional impact thoroughly
• Clinician Judgment: Expert assessment captures what self-report might miss
• Differential Diagnosis: Helps rule out conditions mimicking PTSD
• Research Standard: Used in all PTSD clinical trials; recognized internationally

PHQ-9 (Patient Health Questionnaire-9)

The PHQ-9 screens for major depression and tracks mood throughout treatment.

Why Depression Screening Matters for PTSD

Major depression is comorbid in 50-80% of PTSD cases. Overlapping symptoms (sleep problems, concentration difficulty, guilt, anhedonia) can make it difficult to distinguish which condition is primary. PHQ-9 clarifies the extent of depressive symptoms and guides medication selection.

What PHQ-9 Measures

9 items assessing core depression symptoms:

1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling/staying asleep or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself or that you're a failure
7. Trouble concentrating on tasks
8. Moving slowly or speaking slowly, or the opposite (being fidgety)
9. Thoughts of harming yourself or being better off dead

Scoring PHQ-9

Each item rated 0-3 (Not at all, Several days, More than half the days, Nearly every day):

Total Score:

• 0-4: No depression
• 5-9: Mild depression
• 10-14: Moderate depression
• 15-19: Moderately severe depression
• 20-27: Severe depression

At KwikPsych: PHQ-9 is administered at baseline and repeated throughout treatment (weekly or bi-weekly during active treatment). Goal is score <5 by treatment completion.

GAD-7 (Generalized Anxiety Disorder-7)

The GAD-7 screens for generalized anxiety and related anxiety disorders, distinguishing general anxiety from trauma-specific hyperarousal.

What GAD-7 Measures

7 items assessing core anxiety symptoms:

1. Feeling nervous, anxious, or on edge
2. Unable to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it's hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful might happen

Scoring GAD-7

Each item rated 0-3:

Total Score:

• 0-4: No anxiety
• 5-9: Mild anxiety
• 10-14: Moderate anxiety
• 15-21: Severe anxiety

PTSD vs. GAD: Why the Distinction Matters

• GAD: Free-floating worry about future threats; present since childhood; context-independent
• PTSD Hyperarousal: Fear-based reactivity to trauma reminders; develops after trauma; context-dependent

This distinction affects treatment: PTSD-specific therapies (CPT, PE, EMDR) target trauma memory, while GAD treatment focuses on worry and intolerance of uncertainty. Some SSRIs work for both (sertraline, paroxetine); others are better for one condition.

Structured Clinical Interview and Differential Diagnosis

Beyond standardized tools, Dr. Thangada conducts a comprehensive clinical interview to:

Confirm PTSD Diagnosis:

• Detailed exploration of each DSM-5-TR symptom
• Onset and duration of symptoms
• Functional impairment assessment
• Temporal relationship between trauma and symptom onset

Rule Out Related Conditions:

Acute Stress Disorder (ASD)

• Occurs 3 days to 1 month after trauma
• Shares PTSD symptoms but shorter duration
• If symptoms persist beyond 1 month, diagnosis becomes PTSD

Adjustment Disorder

• Distress from identifiable stressor
• Symptoms less severe than PTSD
• Less specific to trauma
• More reactive to general life stress

Complex Grief

• Intense grief following loss
• Does not include flashbacks or full PTSD symptomatology
• Does not meet shock/trauma criterion

Other Anxiety Disorders

• Panic disorder: Unexpected panic attacks
• Social anxiety: Fear of social situations
• Specific phobias: Intense fear of specific objects/situations
• GAD: Free-floating worry (assessed with GAD-7)

Substance-Induced Symptoms

• Alcohol/benzodiazepine withdrawal: Mimics hyperarousal
• Stimulant use: Causes hypervigilance
• Assessment clarifies whether symptoms are substance-related vs. PTSD

Medical Conditions Mimicking PTSD:

• Hyperthyroidism: Causes anxiety, hyperarousal
• Sleep apnea: Causes nightmares, arousal
• Chronic pain: Often comorbid; exacerbates PTSD
• Traumatic brain injury: May cause concentration problems, irritability, sleep disruption

The PTSD Assessment Process at KwikPsych

Step 1: Scheduling and Initial Intake (Week 1)

Phone Consultation:

• Brief overview of your trauma and current symptoms
• Discussion of assessment type and timeline
• Scheduling 60-90 minute initial appointment

Intake Forms (completed before appointment):

• Demographics and contact information
• Insurance information
• Detailed trauma history questionnaire
• Medical history and current medications
• Family psychiatric history
• Substance use history
• Suicide screening
• Previous mental health treatment

Step 2: Comprehensive Psychiatric Evaluation (Week 1)

Initial Appointment with Dr. Monika Thangada (60-90 minutes):

Chief Complaint and Symptom Review

• What brings you in?
• Timeline of PTSD symptoms
• Severity and functional impact

Detailed Trauma History (conducted with trauma-informed care)

• Specific traumatic event(s) and circumstances
• Your reaction during the trauma
• Ongoing safety concerns
• Secondary losses resulting from trauma

Current Symptom Assessment

• Intrusion symptoms (flashbacks, nightmares, intrusive memories)
• Avoidance behaviors
• Negative cognitions and mood changes
• Hyperarousal and reactivity

Psychiatric History

• Previous diagnoses and treatments
• Family history of mental illness
• Prior therapy or medication trials
• Substance use history and current use
• Suicide risk assessment

Medical History

• Current medical conditions
• Current medications and supplements
• Allergies and adverse reactions
• History of traumatic brain injury
• Sleep and pain history

Functional Assessment

• Work/school performance
• Relationships and social engagement
• Self-care and daily functioning
• Impact on quality of life

Safety Planning

• Suicide risk and protective factors
• Crisis resources and support

Step 3: Standardized Assessment Tools (Weeks 1-2)

PCL-5 Completion (5-10 minutes)

• Self-report screening for PTSD
• Provides severity rating and diagnostic guidance

PHQ-9 Completion (5 minutes)

• Screen for comorbid depression

GAD-7 Completion (5 minutes)

• Screen for comorbid anxiety

CAPS-5 Administration (45-90 minutes)

Either same week or following week (can be split over 2 sessions):

• Gold-standard diagnostic interview
• Detailed exploration of each PTSD symptom
• Behavioral observation and distress assessment
• Functional impairment rating
• Differential diagnosis confirmation

Step 4: Medical Evaluation (as indicated)

Physical Examination:

• Vital signs
• General health screening

Labs (if clinically indicated):

• Thyroid function (TSH)
• Metabolic panel
• Other labs based on symptoms and medical history

Step 5: Results and Recommendations (Week 2-3)

Follow-Up Appointment with Dr. Thangada (30-60 minutes):

Detailed Results Review:

• PCL-5, PHQ-9, GAD-7, CAPS-5 interpretation
• What the scores mean
• Formal diagnosis confirmation

Clinical Formulation:

• Summary of findings
• Confirmation of PTSD diagnosis
• Identification of comorbid conditions
• Contributing factors and protective factors

Treatment Recommendations:

• Recommended therapy modality (CPT, PE, EMDR, TF-CBT, etc.)
• Medication recommendations
• Frequency and duration of treatment
• Expected timeline for improvement
• Alternative options discussed

Insurance and Logistics:

• Insurance verification and coverage
• Cost discussion
• Scheduling therapy and/or medication management
• Telehealth or in-person options

Crisis Resources:

• 988 Suicide & Crisis Lifeline
• Emergency contacts
• Safety planning

Interpreting Your Assessment Results

PCL-5 Results

Your Score: 42 (Example)

"Your PCL-5 score is 42, indicating severe PTSD symptoms. This means:

• Your symptoms align with a PTSD diagnosis
• Treatment is needed to achieve recovery
• With evidence-based therapy and medication, most people with scores in this range achieve substantial improvement within 12-16 weeks"

PCL-5 Progress Over Treatment:

Interpretation at End of Treatment:

"Your PCL-5 score has improved from 42 to 8, representing a 81% reduction in symptoms. You've achieved remission-level functioning and are ready for transition to maintenance phase."

CAPS-5 Results

Your CAPS-5 Score: 48 (Example)

"Your CAPS-5 score is 48, falling in the 'severe PTSD' range. This diagnostic interview confirms:

• PTSD Diagnosis: CONFIRMED
• You meet all four symptom cluster criteria
• Symptom onset and functional impairment are consistent with PTSD

• Severity: Severe
• Your symptoms significantly interfere with work, relationships, and daily activities
• Intensive treatment (therapy + medication) is recommended

• Differential Diagnosis Assessment:
• Not acute stress disorder (symptoms have persisted >1 month)
• Not adjustment disorder (symptoms are trauma-specific and severe)
• Not primarily depression or anxiety (though PHQ-9 and GAD-7 suggest mild comorbidity)"

PHQ-9 Results

Your PHQ-9 Score: 14 (Example)

"Your PHQ-9 score is 14, indicating moderate depression. This suggests:

• You have clinically significant depressive symptoms
• Depression is comorbid with your PTSD
• Medication (SSRI antidepressant) is recommended to address both PTSD and depression
• Therapy will address both trauma and depressive thinking"

GAD-7 Results

Your GAD-7 Score: 8 (Example)

"Your GAD-7 score is 8, indicating mild anxiety. This suggests:

• Your anxiety is likely trauma-related hyperarousal (not generalized anxiety disorder)
• Your PTSD treatment will target this hyperarousal
• SSRI medication will help regulate both PTSD and anxiety symptoms"

Treatment Plan Based on Assessment

Example Integration of Assessment Results into Treatment Plan

Assessment Findings:

• CAPS-5: 48 (Severe PTSD confirmed)
• PCL-5: 42
• PHQ-9: 14 (Moderate depression)
• GAD-7: 8 (Mild anxiety)
• Clinical interview: Single-incident trauma (motor vehicle accident 2 years ago), recurrent nightmares, driving avoidance, emotional numbing, guilt about survival of passenger who was injured

Recommended Treatment Plan:

1. Therapy: Prolonged Exposure (PE) — effective for nightmares, avoidance, and driving anxiety
2. Medication: Sertraline (SSRI) — addresses PTSD, depression, anxiety; helps with intrusive thoughts
3. Frequency: Weekly individual therapy (50-60 min) + monthly medication management
4. Timeline: 12 weeks intensive treatment, then transition to maintenance
5. Expected Outcome: 60-80% symptom reduction within 12 weeks; PCL-5 score expected to drop from 42 to 10-15 by week 12

FAQ: PTSD Assessment and Testing

Q: Is PTSD assessment free?

A: It depends on your insurance and whether you choose self-pay. Insurance typically covers psychiatric evaluation. Self-pay rate is $299 for initial evaluation.

Q: How long does a full PTSD assessment take?

A: Comprehensive assessment takes 2-3 hours across 1-2 appointments (60-90 min initial appointment + 45-90 min CAPS-5 + follow-up).

Q: Do I need CAPS-5 if I already completed PCL-5?

A: PCL-5 is an excellent screening tool and is sufficient for many purposes. CAPS-5 provides gold-standard diagnostic confirmation and is typically completed if PTSD diagnosis is suspected and will guide intensive treatment planning.

Q: Can I do assessment via telehealth?

A: Initial evaluation can be via telehealth. CAPS-5 is ideally in-person (better for observing affect and distress) but can be completed via telehealth if necessary.

Q: What if my assessment results don't confirm PTSD?

A: Assessment results guide treatment regardless. You might have acute stress (will resolve), adjustment disorder, depression, or another condition. The assessment clarifies the diagnosis, which is crucial for appropriate treatment.

Q: Will my assessment results be used against me (employment, custody, benefits)?

A: Your assessment is confidential medical information. You control who has access to your results. However, if you're applying for disability or involved in legal proceedings, you may choose to share results. Discuss confidentiality and use of results with Dr. Thangada.

Q: How often should I retake PCL-5 during treatment?

A: Typically weekly during active treatment (weeks 1-12), then monthly during consolidation, then at discharge. Repeated PCL-5 creates an objective progress chart.

Q: What if my assessment shows severe PTSD and I'm scared?

A: A severe diagnosis can feel overwhelming, but it also means you know what to address. Evidence-based treatment has strong success rates even for severe PTSD. Dr. Thangada will discuss treatment options and expected timeline for improvement.

Accessibility and Accommodations

We accommodate:

• Telehealth appointments (no travel to Austin needed)
• Flexible scheduling
• Interpreter services (if needed)
• Extended time (if trauma responses or disabilities affect processing)
• Written materials after appointments

Crisis Support

If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988, or text HOME to 741741 (Crisis Text Line).

Schedule Your PTSD Assessment Today

Accurate assessment is the first step toward recovery. Dr. Monika Thangada and our clinical team provide comprehensive, evidence-based PTSD testing and assessment.

Contact KwikPsych:

• Phone: 737-367-1230
• Address: 12335 Hymeadow Dr, Suite 450, Austin, TX 78750
• Telehealth: Available throughout Texas

Your assessment creates a personalized roadmap to recovery. You deserve accurate diagnosis and appropriate, evidence-based treatment.

Related Resources

• Understanding PTSD: Complete Condition Guide
• Comprehensive PTSD Treatment
• PTSD Evaluation & Medication Management
• PTSD Therapy: Evidence-Based Modalities
• National Center for PTSD - Assessment Tools
• VA Clinical Practice Guideline for PTSD